HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Savania Nagiah Selected Research

Fusaric Acid

1/2021Fusaric acid decreases p53 expression by altering promoter methylation and m6A RNA methylation in human hepatocellular carcinoma (HepG2) cells.
1/2020Molecular docking and mechanisms of fusaric acid induced mitochondrial sirtuin aberrations in glycolytically and oxidatively poised human hepatocellular carcinoma (HepG2) cells.
1/2019Fusaric acid-induced promoter methylation of DNA methyltransferases triggers DNA hypomethylation in human hepatocellular carcinoma (HepG2) cells.
11/2017Fusaric Acid Induces DNA Damage and Post-Translational Modifications of p53 in Human Hepatocellular Carcinoma (HepG2 ) Cells.
9/2016Fusaric acid induces mitochondrial stress in human hepatocellular carcinoma (HepG2) cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Savania Nagiah Research Topics

Disease

10Hepatocellular Carcinoma (Hepatoma)
04/2021 - 09/2015
4Neoplasms (Cancer)
01/2020 - 12/2015
3Mitochondrial Diseases (Mitochondrial Disease)
05/2020 - 05/2016
2Gallstones (Gallstone)
03/2021 - 01/2021
2Cholelithiasis
03/2021 - 01/2021
2Insulin Resistance
01/2020 - 03/2016
2Inflammation (Inflammations)
06/2019 - 10/2017
2Necrosis
04/2018 - 09/2016
1Fibrosis (Cirrhosis)
04/2022
1Neuroinflammatory Diseases
07/2021
1Cognitive Dysfunction
07/2021
1Infections
10/2019
1Hypoxia (Hypoxemia)
06/2019
1Mycotoxicosis (Fungus Poisoning)
02/2019
1Hyperglycemia
10/2018
1Pre-Eclampsia (Preeclampsia)
01/2017
1Metabolic Syndrome (Dysmetabolic Syndrome X)
05/2016
1Lipodystrophy
05/2016

Drug/Important Bio-Agent (IBA)

5Fusaric AcidIBA
01/2021 - 09/2016
3AntioxidantsIBA
02/2019 - 12/2015
2Metformin (Glucophage)FDA LinkGeneric
07/2021 - 05/2020
2CholesterolIBA
03/2021 - 01/2021
2ochratoxin AIBA
06/2019 - 10/2017
2CaspasesIBA
10/2017 - 09/2016
2Zidovudine (Retrovir)FDA LinkGeneric
05/2016 - 09/2015
2Stavudine (Zerit)FDA LinkGeneric
05/2016 - 09/2015
2Tenofovir (Viread)FDA Link
05/2016 - 09/2015
1NF-kappa B (NF-kB)IBA
04/2022
1Cytochrome P-450 CYP1B1IBA
04/2022
1PPAR gammaIBA
04/2022
1InflammasomesIBA
07/2021
1MicroRNAs (MicroRNA)IBA
07/2021
1deoxynivalenolIBA
04/2021
1LipidsIBA
03/2021
1LDL Lipoproteins (beta Lipoproteins)IBA
03/2021
1Proteins (Proteins, Gene)FDA Link
01/2020
1SirtuinsIBA
01/2020
1Anti-Bacterial Agents (Antibiotics)IBA
10/2019
1Ethambutol (Myambutol)FDA LinkGeneric
10/2019
1Reactive Oxygen Species (Oxygen Radicals)IBA
06/2019
1MycotoxinsIBA
06/2019
1Oxygen (Dioxygen)IBA
06/2019
1Transcription Factors (Transcription Factor)IBA
06/2019
1Biomarkers (Surrogate Marker)IBA
06/2019
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2019
1Niacin (Nicotinic Acid)FDA LinkGeneric
03/2019
1FumonisinsIBA
02/2019
1fumonisin B1IBA
02/2019
1DNA (Deoxyribonucleic Acid)IBA
01/2019
1MethyltransferasesIBA
01/2019
1ErythritolIBA
10/2018
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
05/2018
1Mevalonic Acid (Mevalonate)IBA
05/2018
1Pharmaceutical PreparationsIBA
05/2018
1Atorvastatin (Lipitor)FDA Link
05/2018
1Propidium (Propidium Iodide)IBA
04/2018
1PhosphatidylserinesIBA
04/2018
1Adenosine Triphosphate (ATP)IBA
10/2017
1CytokinesIBA
01/2017
1Sirtuin 3IBA
09/2016
1NucleosidesIBA
05/2016
14-hydroxyisoleucineIBA
03/2016
1ResveratrolIBA
12/2015
1Mitochondrial DNA (mtDNA)IBA
09/2015

Therapy/Procedure

3Therapeutics
03/2021 - 05/2016
1Art Therapy
01/2021
1Cholecystectomy
01/2021
1Highly Active Antiretroviral Therapy (HAART)
01/2017